Russia's new law on medicines lacks orphan drugs clause
This article was originally published in Scrip
Russia's president Dmitriy Medvedev has signed into law the controversial bill on the circulation of medicines, following its approval by both chambers of the national parliament (scripnews.com, 19 March 2010). It will come into force on 1 September 2010.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.